OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
January 02, 2023
Celegance’s Dossplorer can import product registration dossiers and ready regulatory submissions for electronic common technical documents compliance.
Bio-Rad Laboratories’ Pioneer Antibody Discovery Platform is an antibody discovery service specifically designed to develop best-in-class biologic candidates.
December 22, 2022
Webinar Date/Time: Thursday January 19, 2023 at 11am EST | 10am CST | 8am PST
December 21, 2022
The complaint states the company introduced adulterated drugs into interstate commerce that were manufactured, processed, packed, or held under conditions that defy current good manufacturing practice (CGMP) requirements.
December 20, 2022
In this episode of the Drug Solutions Podcast, Meg Rivers discusses outsourcing strategies in biopharma with Jeff Henderson, key account manager of Vetter.
December 16, 2022
Some manufacturers are developing smaller, more mobile drug manufacturing processes for point-of-use patient care.
December 14, 2022
Emmes’ new facility is designed to support clients conducting cell and gene therapy research worldwide.
Thermo Fisher Scientific’s new facility in Hangzhou, China, is designed to boost biologics and sterile development and manufacturing capabilities in the Asia-Pacific region.
December 08, 2022
The most safe and effective therapies demand the highest data quality.
December 07, 2022
In this episode of the Drug Solutions Podcast, Chris Spivey interviews executives at Shabas Solutions LLC, who ran the overseas QMM pilot project.